A5046898491- Dermatological and COVID-19 studies
- Hair Growth and Disorders
- Dermatologic Treatments and Research
- Autoimmune Bullous Skin Diseases
- Autoimmune and Inflammatory Disorders
- Parvovirus B19 Infection Studies
- Nail Diseases and Treatments
- Streptococcal Infections and Treatments
- Dermatology and Skin Diseases
- Cancer and Skin Lesions
- Genital Health and Disease
- Chemotherapy-related skin toxicity
- Genetic and rare skin diseases.
- Cutaneous lymphoproliferative disorders research
- Nonmelanoma Skin Cancer Studies
- Urticaria and Related Conditions
- Body Contouring and Surgery
- Vascular Malformations and Hemangiomas
- Skin Diseases and Diabetes
- Dermatological and Skeletal Disorders
- Drug-Induced Adverse Reactions
- Eosinophilic Disorders and Syndromes
- Reconstructive Facial Surgery Techniques
- Cutaneous Melanoma Detection and Management
- Dermatological diseases and infestations
Instituto Ramón y Cajal de Investigación Sanitaria
2019-2025
Universidad de Alcalá
2019-2025
Hospital Universitario Ramón y Cajal
2019-2025
Grupo ACS (Spain)
2024-2025
Instituto Cajal
2018-2023
University Dermatology
2021
Marconi University
2020
Central Michigan University
2020
Michigan United
2020
Real Academia Española
2020
COVID‐19 is an infectious disease caused by severe acute respiratory coronavirus 2 (SARS‐CoV‐2). Vesicular skin rashes have been reported as associated with COVID‐19, but there little information about this cutaneous manifestation. We designed a prospective observational study of patients diagnosed who had vesicular lesions. Clinical characterization findings was conducted dermatologists. When possible, histological analysis and detection SARS‐CoV‐2 in the content vesicles performed. In...
Figure 1).Their HAP scores gradually increased, and the hypotrichosis in patient with TRPS1 did not improve (Figure 2A).Hair shaft diameters were increased every participant LIPH pathogenic variants 2B andC).There no serious adverse events, but some mild events reported (dry skin on scalp, trichiasis, hypertrichosis entire body).Discussion | Lysophosphatidic acids bind P2Y5 receptor hair follicle epithelium activate growth. 5In ARWH due to variants, loss-of-function lead a deficiency of...
The objective of our study was to analyze the effectiveness oral minoxidil on frontotemporal hairline in patients with FFA. We conducted a retrospective, descriptive, multicenter 2 Brazilian and 1 Spanish centers. Responses were graded scale 3 positive points. A total 122 included. Subjective improvement density observed 45.1% patients, which categorized as mild (34.4%), moderate (9.0%), excellent (1.6%). Hair improved 57.4% patients' interparietal. Additionally, 25.4% 3.3% experienced...
Acute telogen effluvium has been recognised as a dermatological sequela of COVID-19.
Androgenetic alopecia (AGA) is common. While topical minoxidil remains the only FDA-approved therapeutic for AGA, its efficacy limited in stimulating clinically significant hair regrowth over longer term. Oral minoxidil, which used off-label, a promising alternative; however, effectiveness and underlying mechanisms warrant further investigation. To elucidate site of action infer physiological responses to oral patients with AGA. Forty-one AGA underwent 6 months low-dose treatment. Minoxidil...
Folliculitis decalvans (FD) is a rare primary neutrophilic scarring alopecia whose etiology has not been completely elucidated yet.The aim of the study was to determine if follicular microbiota residing in FD-affected hair follicles had distinct microbiological signature and an aberrant immune response present pathogenesis FD.We conducted cross-sectional 10 patients affected by FD. Trichoscopy-guided biopsies were taken from healthy scalp identify microbiome using next-generation sequencing....
Frontal fibrosing alopecia (FFA) is a cicatricial that results in hair follicle destruction on the frontotemporal hairline.To our knowledge, association of inflammation with progression disease has not been studied prospectively.
Up to 20% of patients with coronavirus disease 2019 develop cutaneous manifestations such as erythematous rash, rash petechiae, vesicular acral ischemia, livedo reticularis, and widespread urticaria.1Joob B. Wiwanitkit V. COVID-19 can present a be mistaken for dengue.J Am Acad Dermatol. 2020; 82: e177Abstract Full Text PDF PubMed Scopus (337) Google Scholar,2Recalcati S. Cutaneous in COVID-19: first perspective.J Eur Dermatol Venereol. 34: e212-e213Crossref (928) Scholar The appropriate...